Emergency Preparedness and Response

Follow Us on Twitter

@FDA_MCMi disclaimer icon

FDA's Medical Countermeasure initiative (MCMi) is using Twitter disclaimer icon as part of its communication and outreach program. MCMi's main goal for Twitter is to help consumers and stakeholders keep up-to-date on MCMi-related issues and to address frequently asked questions in a convenient way. Messages on Twitter will include press releases, new web postings, and highlights from FDA web sites, and MCM-related information from a variety of sources.

Want more than 140 characters? Subscribe to our email alerts.

Disclaimer 

We may not be able to respond to replies or direct messages. Please send questions or comments to AskMCMi@fda.hhs.gov.
Please do not post any private, personal, or proprietary information here. Send inquiries to AskMCMi@fda.hhs.gov.
Messages, retweets, followers,and those we are following do not in any way imply endorsement of any product or organization.

Website Policies

Privacy statement; third-party websites

Contact FDA

301-796-8510
FDA's Office of Counterterrorism and Emerging Threats

Dr. Luciana Borio

Assistant Commissioner for Counterterrorism Policy and Director, Office of Counterterrorism and Emerging Threats

Page Last Updated: 01/27/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.